Concluding its discussion on factor Xa inhibitor clinical trials, the panel reviews bleeding data from the COMPASS study.
Clinical presentations such as vaso-occlusive crises and other chronic complications associated with the presence of sickle cell disease.
Yusuf Yazici, MD, chief medical officer of Samumed, discusses SM04690(Lorecivivint) at ACR 2019.
What does a modern food allergy care team look like, and what are the individual roles?
With the recent FDA approval, ustekinumab could be the first choice to treat ulcerative colitis.
Views Count: 891,459
Total Videos: 3,508
Comment Count: 0
By using this site you are agreeing to our terms of service.